Trading a IRON straddle lets you take a pure volatility position on Disc Medicine Inc without committing to a direction. Disc Medicine Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate IRON straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on IRON profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Disc Medicine Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the IRON straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the IRON straddle is the cleanest expression of that view. Our scanner prices every IRON straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a IRON straddle into a catalyst or short a IRON straddle to harvest decay, the options straddle setups that matter are all in one place.
